Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-18-011963
Filing Date
2018-05-08
Accepted
2018-05-08 20:08:53
Documents
2
Period of Report
2018-05-08

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 8061
2 EX-24 DOCUMENT attachment1.htm EX-24 4105
  Complete submission text file 0000899243-18-011963.txt   13518
Mailing Address 515 GALVESTON DR REDWOOD CITY CA 94063
Business Address
GILL SIMBA (Reporting) CIK: 0001180763 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38473 | Film No.: 18816368

Mailing Address 620 MEMORIAL DRIVE SUITE 200 WEST CAMBRIDGE MA 02139
Business Address 620 MEMORIAL DRIVE SUITE 200 WEST CAMBRIDGE MA 02139 617 870 8281
Evelo Biosciences, Inc. (Issuer) CIK: 0001694665 (see all company filings)

EIN.: 465594527 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations